In Collaboration with

Endpoints is the biopharma and healthcare industries' trusted source for up-to-the-moment news, in-depth reporting on science and business, and coverage of the people, companies and money that drive innovation.

Strategic Partner

Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more than 21,000 global professionals works in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind, increasing access and participation to make clinical research a care option for anyone, anywhere. Our depth of industry knowledge and strong track record gained over the past 40 years is moving the industry forward and advancing clinical research in healthcare’s most complex areas, while our innovation ecosystem offers quality solutions to make every phase of the clinical trial process more efficient. With the people, insight and focus on operational excellence, we work With HeartTM every day to treat patients with dignity and continuously learn from their experiences, so every trial makes a difference. This approach continues to earn us recognition industrywide, with Parexel being the recipient of the 2024 and 2023 Society for Clinical Research Sites (SCRS) Eagle Award for advancing the clinical research profession through strong site partnerships and named “Top CRO to Work With” by investigative sites worldwide in the 2023 WCG CenterWatch Global Site Relationship Benchmark Survey.

Associate Sponsor

Ecolab Life Sciences, a division of Ecolab, is a global leader in technologies and services for biopharmaceutical and pharmaceutical manufacturers. With more than a century of innovation, we partner with scientists, engineers, and manufacturers to enhance productivity, reduce costs, and accelerate the development of critical therapeutics.  We deliver comprehensive, end-to-end solutions, including bio-decontamination, drug purification, and support with active pharmaceutical ingredients (APIs). These solutions are tailored to the complex demands of highly regulated industries. Our Purolite™ Resins portfolio features patented Jetting technology for high-yield purification of monoclonal antibodies (mAbs) and recombinant proteins, consistently meeting strict quality and regulatory standards.  With operations in more than 170 countries, Ecolab Life Sciences provides supply chain security, risk reduction, and continuity for customers worldwide. Our global expertise, paired with local support, helps clients navigate regulatory change, streamline workflows, and bring medicines to market quickly and sustainably.  At every stage, we offer customized, scalable programs and data-driven insights that enable our partners to deliver safe, effective treatments and advance global health.

Associate Sponsor

Since 1926, Kearney has been a leading management consulting firm and trusted partner to three-quarters of the Fortune Global 500 and governments around the world. With a presence across more than 40 countries, our people make us who we are. We work impact first, tackling your toughest challenges with original thinking and a commitment to making change happen together. By your side, we deliver— value, results, impact.

Associate Sponsor

Merz Therapeutics GmbH is dedicated to delivering better outcomes for more patients. With science as its foundation and the patient experience as its focus, the company relentlessly pursues innovative treatments and partnerships to address unmet needs in movement disorders, neurodegenerative conditions, liver disease, and other health conditions that severely impact patients’ quality of life. 

Merz Therapeutics is headquartered in Frankfurt am Main, Germany, and is active in over 80 countries. Merz Therapeutics GmbH is part of the Merz Group, a privately held, family-owned company with a 117-year legacy. With passion and purpose, Merz Therapeutics continues to advance care in specialty neurology in ways that benefit both patients and society. Please visit www.merztherapeutics.com.

Associate Sponsor

Persica Pharmaceuticals is a clinical-stage company developing PP353, a groundbreaking and transformative treatment for chronic Low Back Pain (cLBP) with Modic changes. PP353 is a non-opioid, one-off treatment which addresses an underlying cause of cLBP, rather than just the symptoms. The company’s Phase 1b study, the Modic Trial, reported positive Phase 1b safety and efficacy results in March 2025. Persica is now advancing towards registrational studies.

Associate Sponsor

Zühlke is a global transformation partner, with engineering and innovation in our DNA. We excel in complex, regulated spaces including health and finance, connecting strategy, tech implementation, and operational services to help clients become more effective, resilient businesses.

We have a few packages remaining, get in touch today to see how you can get involved.

© Financial Times Live

FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice